Rutherford Health has announced that its network of Rutherford Cancer Centres have entered into a framework agreement with NHS England under which it will provide cancer treatment and diagnostic imaging services to NHS Trusts and clinical commissioning groups.
The agreement is for a two-year period with an option to extend for a further two years on the agreement of both parties. Services will be provided at a pre-agreed set of prices.
Mike Moran, CEO of Rutherford Health plc, commented: “We are absolutely delighted to have signed this agreement with NHS England. We have been supplying radiotherapy and systemic anti-cancer therapy to NHS patients in 
England and Wales. This agreement streamlines the procurement process and enables NHS organisations in England to commission a range of services directly from us. It means we will provide our services more widely.
“I am particularly pleased to be supporting the fantastic work that the NHS is doing at this extremely challenging time. Providing these much-needed cancer treatments and diagnostic services in dedicated cancer treatment facilities will help relieve pressure on NHS hospitals”.
Rutherford Health operates a network of independent cancer centres, called the Rutherford Cancer Centres. There are currently four centres in Wales, Reading, Northumberland and Liverpool. The centres offer chemotherapy, immunotherapy, radiotherapy and high energy proton beam therapy as well as comprehensive diagnostics services.
Please visit https://www.therutherford.com/ to find out more.
